Open account
☰
Open account
✖

US stocks 2021 year in review: “Big tech” stocks extend their run of dominance

Article By: ,  Head of Market Research
December 29, 2021 2:29 PM

With just a few trading days left in 2021 and volatility likely to be subdued, it’s a great time to review what worked and what didn’t over the past year.

Looking at US stocks, there’s a strong argument that just about everything “worked.” As the chart below shows, every single major sector rose this year, led by energy and real estate, and even the lagging consumer staples, utilities and communication services stocks rose by nearly 20% on (a capitalization-weighted) average:

Source: Stockcharts.com

From a sector rotation perspective, strong performance by energy, technology, financials, and discretionary stocks historically suggests that we’re in a mid- to late- bull market cycle; as we flip the calendars to the 2022, traders should be wary if we start to see traditionally defensive sectors like utilities, consumers stapes, and health care start to outperform as a potential signal that the bull market may be peaking and a bear market may be around the corner.

Drilling down to an individual stock level, these were the top 10 performers in the S&P 500 and their sectors this year:

  1. Devon Energy (Energy) +199%
  2. Marathon Oil (Energy) +151%
  3. Fortinet (Technology) +146%
  4. Signature Bank (Financials) +142%
  5. Ford Motor (Discretionary) +137%
  6. NVIDIA (Technology) +132%
  7. Diamondback Energy (Energy) +132%
  8. Moderna (Health Care) +131%
  9. Bath & Body Works (Discretionary) +130%
  10. Nucor (Materials) +118%

And, perhaps more importantly, these 10 stocks were the biggest contributors to the S&P 500’s impressive nearly 30% gain in 2021:

  1. Microsoft (Technology) +55%
  2. Apple (Technology) +36%
  3. NVIDIA (Technology) +132%
  4. Alphabet (Communication Services) +67%
  5. Tesla (Discretionary) +27%
  6. Meta Platforms / Facebook (Communication Services) +27%
  7. Home Depot (Discretionary) +56%
  8. UnitedHealth Group (Health Care) +45%
  9. Pfizer (Health Care) +64%
  10. Berkshire Hathaway (Financials) +29%
Once again, the megacap technology stocks drove most of the gains in the overall indices, leading to an even heavier weighting in these names heading into 2022. For more on the outlook for these tech behemoths, see my colleague Josh Warner’s report “Big Tech stocks: What will they face in 2022?” as part of our full 2022 Market Outlook guide.

How to trade with City Index

You can trade with City Index by following these four easy steps:

  1. Open an account, or log in if you’re already a customer 

    • Open an account in the UK
    • Open an account in Australia
    • Open an account in Singapore

  2. Search for the company you want to trade in our award-winning platform 
  3. Choose your position and size, and your stop and limit levels 
  4. Place the trade

This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.

StoneX Financial Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the StoneX group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), StoneX Financial Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact StoneX Financial Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.

In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither StoneX Financial Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.

StoneX Financial Pte. Ltd. is not under any obligation to update this report.

Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit www.cityindex.com/en-sg/terms-and-policies for the complete Risk Disclosure Statement.

ALL TRADING INVOLVES RISKS. LOSSES CAN EXCEED DEPOSITS.

City Index is a trading name of StoneX Financial Pte. Ltd. (“SFP”) for the offering of dealing services in Contracts for Differences (“CFD”). SFP holds a Capital Markets Services Licence issued by the Monetary Authority of Singapore for Dealing in Exchange-Traded Derivatives Contracts, Over-the-Counter Derivatives Contracts, and Spot Foreign Exchange Contracts for the Purposes of Leveraged Foreign Exchange Trading. SFP is also both Derivatives Trading and Clearing member of the Singapore Exchange (“SGX”). SFP is a wholly-owned subsidiary of StoneX Group Inc.

The information provided herein is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to invest, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk.

The information does not represent an offer of, or solicitation for, a transaction in any investment product. Any views and opinions expressed may be changed without an update. To understand the risks and costs involved, please visit the section captioned “Important Information” and the “Risk Disclosure Statement”.

The information herein is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation.

StoneX Financial Pte. Ltd. 1 Raffles Place, #18-61, One Raffles Place Tower 2, Singapore 048616. Tel: 6309 1000. Co. Reg. No.: 201130598R.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

© City Index 2024